Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_1
1
13%
Ph phase_4
3
38%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Withdrawn2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 43 (42.9%)
N/A3 (42.9%)

Trials by Status

withdrawn225%
completed450%
not_yet_recruiting113%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8